| 000 | 01769 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516042946.0 | ||
| 264 | 0 | _c20120521 | |
| 008 | 201205s 0 0 eng d | ||
| 022 | _a1095-953X | ||
| 024 | 7 |
_a10.1016/j.nbd.2011.05.017 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aArmentero, Marie-Therese | |
| 245 | 0 | 0 |
_aAdhesion molecules as potential targets for neuroprotection in a rodent model of Parkinson's disease. _h[electronic resource] |
| 260 |
_bNeurobiology of disease _cSep 2011 |
||
| 300 |
_a663-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCell Adhesion Molecules _xmetabolism |
| 650 | 0 | 4 |
_aCorpus Striatum _xdrug effects |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aFreund's Adjuvant _xpharmacology |
| 650 | 0 | 4 |
_aIntercellular Adhesion Molecule-1 _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNerve Degeneration _xdrug therapy |
| 650 | 0 | 4 |
_aNeural Cell Adhesion Molecules _xmetabolism |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xmetabolism |
| 650 | 0 | 4 |
_aOxidopamine _xtoxicity |
| 650 | 0 | 4 |
_aParkinsonian Disorders _xdrug therapy |
| 650 | 0 | 4 |
_aPlatelet Endothelial Cell Adhesion Molecule-1 _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aSubstantia Nigra _xdrug effects |
| 650 | 0 | 4 |
_aSympatholytics _xtoxicity |
| 650 | 0 | 4 |
_aVascular Cell Adhesion Molecule-1 _xmetabolism |
| 700 | 1 | _aLevandis, Giovanna | |
| 700 | 1 | _aBazzini, Eleonora | |
| 700 | 1 | _aCerri, Silvia | |
| 700 | 1 | _aGhezzi, Cristina | |
| 700 | 1 | _aBlandini, Fabio | |
| 773 | 0 |
_tNeurobiology of disease _gvol. 43 _gno. 3 _gp. 663-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.nbd.2011.05.017 _zAvailable from publisher's website |
| 999 |
_c20938816 _d20938816 |
||